Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 2002 Aug;40(8):3066–3067. doi: 10.1128/JCM.40.8.3066-3067.2002

Detection of Enteroaggregative Escherichia coli with Formalin-Preserved HEp-2 Cells

Mohamad S Miqdady 1, Zhi-Dong Jiang 2, James P Nataro 3, Herbert L DuPont 1,2,4,*
PMCID: PMC120651  PMID: 12149382

Abstract

Formalin-stored HEp-2 cells were used to assay Escherichia coli for adherence. Cells refrigerated in formalin for up to 28 days and used in a wet assay format demonstrated an assay sensitivity ranging from 94 to 98% to detect enteroaggregative E. coli (EAEC). HEp-2 cells first fixed and stored with formalin and then stored dry in ambient conditions for 6 weeks demonstrated an assay sensitivity of 92% to detect EAEC. Using formalin-fixed HEp-2 cells will improve the efficiency of EAEC identification.


Enteroaggregative Escherichia coli (EAEC) has been identified as a cause of bacterial gastroenteritis in developed and developing countries (1, 2, 3, 11, 13).

The true incidence of EAEC infection is underestimated because the current assay is performed only in research laboratories. The standard assay for EAEC, demonstration of aggregative attachment of organisms to human epithelial (HEp-2) cells, is time-consuming to set up and prone to contamination.

The use of formalin-fixed HEp-2 cells offers a means of studying EAEC in a time-efficient way, eliminating the risk of contamination.

The organisms were retrieved from stool samples of U.S. college students during their short-term stays in Guadalajara, Mexico, in the summer of 1999 (1). Consent was obtained and approved by University of Texas Committee for the Protection of Human Subjects. In Mexico, E. coli cells were identified as lactose-fermenting gram-negative organisms on a MacConkey plate and by biochemical testing. Five colonies of E. coli were preserved in peptone stabs, shipped to Houston, Tex., and stored at room temperature. In Houston, E. coli cells were retrieved from the peptone stabs, grown on MacConkey agar plates, and then incubated overnight at 37°C in tryptic soy broth (TSB) with 1% mannose. Then, E. coli isolates were tested for aggregative adherence by using standard HEp-2 cell assay (1, 2): HEp-2 cells monolayers were added to a 24-well plate, and minimal essential medium (MEM) (0.5 ml) with 1% mannose was added to each well along with 25 μl of bacterial culture. The plates were incubated for 3 h at 37°C in room air. Afterwards, the plates were exposed to cold methanol for 10 min for fixation, followed by exposure to 10% crystal violet for staining. Finally, the slide covers were placed over glass slides by using Permount and viewed under light microscopy. EAEC strain JM 221 was used as a positive control, and EAEC strain HS was used as a negative control. Selected samples represented all HEp-2-cell-positive and -negative E. coli isolates from our studies carried out in 1999 (1).

Fresh HEp-2 cells (ca. 500 cells/well) were added to 24-well plates with a coverslip in each well and incubated in MEM overnight in a tissue culture incubator at 37°C with 5% CO2 to achieve confluence of growth of approximately 75%. At this time, MEM was aspirated, and 1 ml of formalin (10%; EM Science) was then added to each well to fix HEp-2 cells to coverslips and the cells were stored at 4°C for up to 28 days (wet assay).

After 28 days of storing HEp-2 cells with formalin, formalin was aspirated from the wells and the cells were stored at room temperature for an additional 6 weeks (dry assay).

On the day of the assay, formalin-fixed monolayers were added to a 24-well plate, washed with phosphate-buffered saline (PBS) five times to remove the formalin, and then processed using the standard HEp-2 cell assay methods (1, 2) described above.

Samples were analyzed in duplicate to eliminate potential technical errors. Discordant pair results were repeated in duplicate, using the same technique.

Sensitivity, specificity, and positive and negative predictive values were compared between the standard HEp-2 cells assay and the formalin-fixed HEp-2 cells assays by using McNemar's test for correlated proportions.

The experiments were conducted at the Center for Infectious Diseases, University of Texas-Houston, School of Public Health and Medical School, Houston, Texas.

A total of 86 E. coli isolates were studied. Sixty-two E. coli isolates met criteria for aggregative adherence in the standard HEp-2 adherence. Aggregative adherence was defined, for both assays, as at least one stacked brick microcolony (>5 bacteria) per high-power field. Adherence results for the 62 EAEC isolates tested in the formalin-treated HEp-2 cells are shown in Table 1. EAEC cells adhered equally well (P < 0.05) to formalin-fixed HEp cells, as was seen in the standard assay. A total of nine E. coli isolates showed discordant results when done in duplicate. Six were found to be positive in both sets and three were negative in both sets when retested in duplicate and were considered accordingly in our analyses.

TABLE 1.

Identification of EAECa

Result of formalin-fixed HEp-2 cell assay No. (%) of isolates after formalin fixation (wet assay)
No. (%) of isolates 6 weeks after removing formalin (dry assay)
Day 1 Day 7 Day 14 Day 21 Day 28
Positive for enteroaggregative adherence 61 (98) 58 (94) 58 (94) 61 (98) 58 (94) 57 (92)
Negative for enteroaggregative adherence 1 (2) 4 (6) 4 (6) 1 (2) 4 (6) 5 (8)
Total 62 62 62 62 62 62
a

In an examination of 62 EAEC strains, formalinized HEp-2 cells maintained in formalin (wet assay) or under ambient conditions (dry assay) were identified by a standard HEp-2 cell assay.

All nonadherent E. coli isolates tested using the standard Hep-2 cells assay were also negative for enteroaggregative adherence in the formalin-fixed assays.

Statistical analyses showed a sensitivity of 94 to 98% for the wet assay and 92% for the dry assay compared to the standard assay, with specificity and a positive predictive value of 100% for all assays and a negative predictive value of 83 to 96%.

Since first described in 1985 (8), EAEC has been increasingly recognized as an emerging cause of acute diarrhea in adults and children from diverse regions (1, 5, 7) and is an important cause of travelers' diarrhea (2, 4) and persistent diarrhea in infants living in developing countries (3, 5) and in patients with AIDS (9). EAEC infection causes intestinal inflammation and growth impairment even in asymptomatically infected children (13). A recent study suggests that EAEC may account for a substantial amount of undiagnosed diarrhea in American infants (Mitchell Cohen, personal communication).

The adherence of EAEC to intestinal mucosa is thought to be through fimbrial structures designated aggregative adherence fimbriae I and II (AAF I and II) (10). Currently, the only assay used to detect EAEC strains is the HEp-2 cell assay, which is time-consuming and requires that a trained laboratory technician perform the assay only when cells are available. Furthermore, the cells are prone to contamination which may further delay results.

The results from our experiment using HEp-2 cells maintained in formalin for up to 28 days and previously fixed HEp-2 cells left in the atmosphere at room temperature for 6 weeks showed a high degree of sensitivity and specificity compared with the standard assay.

Since formalin is bactericidal, it is advisable to thoroughly wash the formalin off the HEp-2 cell-coated coverslips and transfer them to a new 24-well plate. Traces of formalin on the coverslip can potentially cause false negative results and might explain the small number of discordant results found between duplicates. Formalin eliminates the risk of contamination of HEp-2 cells, an additional advantage to this assay. One potential cause of false negative results is that EAEC strains may lose their aggregative adherence ability, presumably via spontaneous plasmid loss. To decrease this possibility, we tested the bacterial strains within 1 week of culturing the bacteria.

Although there was a concern about formalin causing false results by clumping fimbriated organisms, this was not observed in our study since all strains negative by the standard assay were also negative in the formalin assays.

The use of formalin did not alter the aggregative adherence ability of HEp-2 cells nor render nonadherent strains positive in the assay. Formalin fixation is achieved by the cross-linking of neighboring protein groups, and surface carbohydrate receptors remain intact. Hicks et al. (6) demonstrated that EAEC adheres in an aggregative pattern to formalin-fixed pediatric intestinal tissue. Furthermore, Spencer et al. suggested that fixing HEp-2 cell monolayers with formalin prevented cell detachment and improved detection of EAEC (12).

Our data suggest that formalin-fixed HEp-2 cells either maintained in formalin or kept at ambient conditions may be used in the assay for at least 6 weeks. We plan to refine this assay further and anticipate that formalin-fixed cells will perform well after much longer fixation periods.

REFERENCES

  • 1.Adachi, J. A., C. D. Ericsson, Z. D. Jiang, M. W. DuPont, S. R. Pallegar, and H. L. DuPont. 2002. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among U.S. travelers to Guadalajara, Mexico. J. Infect. Dis. 185:1681-1683. [DOI] [PubMed]
  • 2.Adachi, J. A., Z. D. Jiang, J. J. Mathewson, M. P. Verenkar, S. Thompson, F. Martinez-Sandoval, R. Steffen, C. D. Ericsson, and H. L. DuPont. 2001. Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin. Infect. Dis. 32:1706-1709. [DOI] [PubMed] [Google Scholar]
  • 3.Bhatnager, S., M. K. Bhan, H. Sommerfelt, S. Sazawal, R. Kumar, and S. Saini. 1993. Enteroaggregative Escherichia coli may be a new pathogen causing acute and persistent diarrhea. Scand. J. Infect. Dis. 25:579-583. [DOI] [PubMed] [Google Scholar]
  • 4.Glandt, M., J. A. Adachi, J. J. Mathewson, Z. D. Jiang, D. DiCesare, D. Ashley, C. D. Ericsson, and H. L. DuPont. 1999. Enteroaggregative Escherichia coli as a cause of traveler's diarrhea: clinical response to ciprofloxacin. Clin. Infect. Dis. 29:335-338. [DOI] [PubMed] [Google Scholar]
  • 5.Ghosh, A. R., G. B. Nair, T. N. Nalik, M. Paul, S. C. Pal, and D. Sen. 1992. Entero-adherent Escherichia coli is an important diarrhoeagenic agent in infants aged below 6 months in Calcutta, India. J. Med. Microbiol. 36:264-268. [DOI] [PubMed] [Google Scholar]
  • 6.Hicks, S., D. C. Candy, and A. D. Phillips. 1996. Adhesion of enteroaggregative Escherichia coli to formalin-fixed intestinal and ureteric epithelia from children. J. Med. Microbiol. 44:362-371. [DOI] [PubMed] [Google Scholar]
  • 7.Mathewson, J. J., R. A. Oberhelman, H. L. DuPont, F. J. de la Cabada, and E. V. Garibay. 1987. Enteroadherent Escherichia coli as a cause of diarrhea among children in Mexico. J. Clin. Microbiol. 25:1917-1919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mathewson, J. J., P. C. Johnson, H. L. DuPont, D. R. Morgan, S. A. Thornton, L. V. Wood, and C. D. Ericsson. 1985. A newly recognized cause of travelers' diarrhea: enteroadherent Escherichia coli. J. Infect. Dis. 151:471-475. [DOI] [PubMed] [Google Scholar]
  • 9.Mathewson, J. J., Z. D. Jiang, A. Zumla, C. Chintu, N. Luo, S. R. Calamari, R. M. Genta, A. Steephen, P. Schwartz, and H. L. DuPont. 1995. HEp-2 cell-adherent Escherichia coli in patients with human immunodeficiency virus-associated diarrhea. J. Infect. Dis. 171:1636-1639. [DOI] [PubMed] [Google Scholar]
  • 10.Nataro, J. P., T. Steiner, and R. L. Guerrant. 1998. Enteroaggregative Escherichia coli. Emerg. Infect. Dis. 4:251-261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Oberhelman, R. A., D. Laborde, R. Mera, E. Starszak, P. Saunders, A. Mirza, G. T. Bessinger, A. Hull. 1998. Colonization with enteroadherent, enterotoxigenic and enterohemorrhagic Escherichia coli among day-care center attendees in New Orleans, Louisiana. Pediatr. Infect. Dis J. 17:1159-1162. [DOI] [PubMed] [Google Scholar]
  • 12.Spencer, J., H. Chart, H. R. Smith, and B. Rowe. 1997. Improved detection of enteroaggregative Escherichia coli using formalin fixed HEp-2 cells. Lett. Appl. Microbiol. 5:325-326. [DOI] [PubMed] [Google Scholar]
  • 13.Steiner, T. S., A. A. Lima, J. P. Nataro, and R. L. Guerrant. 1998. Enteroaggregative Escherichia coli produce intestinal inflammation and growth impairment and cause interleukin-8 release from intestinal epithelial cells. J. Infect. Dis. 177:88-96. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES